GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding GH Research PLC changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 30 | 30 | 0 |
| Shares | 28.5M | 30.0M | +1.54M (+5.4%) |
| Value | $625.2M | $701.0M | +$75.8M (+12.1%) |
New holders (8)
Institutions that held GH Research PLC at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 499,400 | $11.7M | 0.86% |
| Point72 Asset Management, L.P. | 311,000 | $7.26M | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 135,800 | $3.17M | 0.01% |
| Millennium Management LLC | 27,144 | $633.0K | 0.00% |
| HighVista Strategies LLC | 27,010 | $630.0K | 0.50% |
| Virtus ETF Advisers LLC | 7,086 | $165.0K | 0.06% |
| BlackRock Inc. | 4,835 | $113.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 300 | $7.00K | 0.00% |
Sold out (8)
Institutions that held GH Research PLC at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Avidity Partners Management LP | 560,000 | $12.4M |
| Deerfield Management Company, L.P. (Series C) | 405,416 | $8.94M |
| Logos Global Management LP | 324,333 | $6.44M |
| HealthCor Management, L.P. | 164,912 | $3.64M |
| Woodline Partners LP | 48,866 | $1.08M |
| Walleye Capital LLC | 40,748 | $899.0K |
| Pinz Capital Management, LP | 38,408 | $847.0K |
| Schonfeld Strategic Advisors LLC | 17,223 | $380.0K |